Published in Cancer Weekly, December 8th, 1997
A National Institutes of Health (NIH) panel concluded that AZT benefits far outweigh these theoretical risks, but advised that they be discussed when counseling pregnant women with HIV infection. Meanwhile, extensive follow-up studies continue.
The animal studies showed that AZT becomes incorporated into the DNA of monkeys and mice whose mothers received AZT during pregnancy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.